Drug Profile
Anti-CD3 monoclonal antibody-ricin-chain-A conjugate
Alternative Names: Anti-CD3F(ab')2-ricin-toxin-A-chain; SPV-T3a-ricin ALatest Information Update: 10 Aug 1998
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Graft-versus-host disease
Most Recent Events
- 10 Aug 1998 No-Development-Reported for Graft-versus-host disease in Netherlands (Unknown route)
- 10 Aug 1998 No-Development-Reported for Graft-versus-host disease in USA (Unknown route)
- 31 Dec 1996 Preclinical development for Graft-versus-host disease in Netherlands (Unknown route)